Cedric O'Gorman - May 23, 2023 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Medical Officer
Signature
/s/ Cedric O'Gorman
Stock symbol
RLMD
Transactions as of
May 23, 2023
Transactions value $
$31,800
Form type
4
Date filed
5/24/2023, 09:00 AM
Previous filing
Jan 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $31.8K +10K +8264.46% $3.18 10.1K May 23, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2 Purchase prices range from $3.135 to $3.2096 per share, inclusive.